rs1381655903

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate

The NM_032740.4(SFT2D3):​c.118G>C​(p.Ala40Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000843 in 1,305,078 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000059 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0000017 ( 0 hom. )

Consequence

SFT2D3
NM_032740.4 missense

Scores

1
1
17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.84

Publications

0 publications found
Variant links:
Genes affected
SFT2D3 (HGNC:28767): (SFT2 domain containing 3) Predicted to be involved in protein transport and vesicle-mediated transport. Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022]
WDR33 (HGNC:25651): (WD repeat domain 33) This gene encodes a member of the WD repeat protein family. WD repeats are minimally conserved regions of approximately 40 amino acids typically bracketed by gly-his and trp-asp (GH-WD), which may facilitate formation of heterotrimeric or multiprotein complexes. Members of this family are involved in a variety of cellular processes, including cell cycle progression, signal transduction, apoptosis, and gene regulation. This gene is highly expressed in testis and the protein is localized to the nucleus. This gene may play important roles in the mechanisms of cytodifferentiation and/or DNA recombination. Multiple alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.07556081).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SFT2D3NM_032740.4 linkc.118G>C p.Ala40Pro missense_variant Exon 1 of 1 ENST00000310981.6 NP_116129.3 Q587I9
WDR33NM_018383.5 linkc.*4677C>G 3_prime_UTR_variant Exon 22 of 22 ENST00000322313.9 NP_060853.3 Q9C0J8-1
WDR33XM_011511436.2 linkc.*4677C>G 3_prime_UTR_variant Exon 22 of 22 XP_011509738.1 Q9C0J8-1
WDR33XM_005263697.4 linkc.*4847C>G 3_prime_UTR_variant Exon 21 of 21 XP_005263754.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SFT2D3ENST00000310981.6 linkc.118G>C p.Ala40Pro missense_variant Exon 1 of 1 6 NM_032740.4 ENSP00000310803.3 Q587I9
WDR33ENST00000322313.9 linkc.*4677C>G 3_prime_UTR_variant Exon 22 of 22 1 NM_018383.5 ENSP00000325377.3 Q9C0J8-1
ENSG00000293688ENST00000718293.1 linkn.-186C>G upstream_gene_variant

Frequencies

GnomAD3 genomes
AF:
0.0000593
AC:
9
AN:
151814
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00173
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.00000173
AC:
2
AN:
1153156
Hom.:
0
Cov.:
31
AF XY:
0.00
AC XY:
0
AN XY:
559328
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
23224
American (AMR)
AF:
0.00
AC:
0
AN:
9292
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
15342
East Asian (EAS)
AF:
0.0000373
AC:
1
AN:
26838
South Asian (SAS)
AF:
0.00
AC:
0
AN:
39918
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
25400
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3086
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
963880
Other (OTH)
AF:
0.0000217
AC:
1
AN:
46176
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.550
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000592
AC:
9
AN:
151922
Hom.:
0
Cov.:
33
AF XY:
0.0000673
AC XY:
5
AN XY:
74290
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41518
American (AMR)
AF:
0.00
AC:
0
AN:
15242
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3466
East Asian (EAS)
AF:
0.00174
AC:
9
AN:
5178
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10462
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
67918
Other (OTH)
AF:
0.00
AC:
0
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.542
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000151
Asia WGS
AF:
0.00145
AC:
5
AN:
3464

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
May 26, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.118G>C (p.A40P) alteration is located in exon 1 (coding exon 1) of the SFT2D3 gene. This alteration results from a G to C substitution at nucleotide position 118, causing the alanine (A) at amino acid position 40 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.080
BayesDel_addAF
Benign
-0.049
T
BayesDel_noAF
Benign
-0.31
CADD
Benign
8.1
DANN
Benign
0.93
DEOGEN2
Benign
0.018
T
Eigen
Benign
-0.83
Eigen_PC
Benign
-0.85
FATHMM_MKL
Benign
0.42
N
LIST_S2
Benign
0.35
T
M_CAP
Uncertain
0.10
D
MetaRNN
Benign
0.076
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.1
L
PhyloP100
1.8
PrimateAI
Pathogenic
0.81
D
PROVEAN
Benign
-1.3
N
REVEL
Benign
0.14
Sift
Benign
0.079
T
Sift4G
Benign
0.14
T
Polyphen
0.0020
B
Vest4
0.20
MutPred
0.13
Gain of catalytic residue at P39 (P = 0.0133);
MVP
0.47
ClinPred
0.33
T
GERP RS
0.76
PromoterAI
-0.025
Neutral
Varity_R
0.13
gMVP
0.46
Mutation Taster
=76/24
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1381655903; hg19: chr2-128459220; API